You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORIC Exercise Disclosure
Heyman Richard A. · SEC Form 4 · Filed Oct 2, 2026
Exercise
Calculated transaction value
$0
Heyman Richard A. Director
ORIC
Oric Pharmaceuticals
ORIC
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
ORIC daily price context
Close on/before transaction
$12.52
Oct 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 3,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001584759-26-000017
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$92.12K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. ORIC | Exercise | Oct 1, 2026 | $5.6K |
| Oric Pharmaceuticals, Inc. ORIC | Sale | Oct 1, 2026 | $45.2K |
| Oric Pharmaceuticals, Inc. ORIC | Sale | Oct 1, 2026 | $41.33K |
| Oric Pharmaceuticals, Inc. ORIC Current | Exercise | Oct 1, 2026 | $0 |